William New

William New

White House Announces Actions On Patents

The White House today announced measures that it said will advance its battle against "patent trolls", and urged Congress to pass patent reform legislation toward the effort. And the United States Patent and Trademark Office (USPTO) issued a statement on its work in support of the executive actions.

Biopharma Industries, Others Urge Caution In US Patent Reform

A coalition of large and small companies and organisation - including the leading trade associations for the US pharmaceutical and biotechnology industries - has asked the US Congress to use caution in rewriting patent laws so as not to cause unintended harm to their ability to innovate.

WHO, IFRC Tap Swiss Federal Funds For New Buildings

The World Health Organization and International Federation of the Red Cross and Red Crescent have received approval of the Swiss Federal Council to receive millions of Swiss francs in loans for the purpose of planning new buildings in Geneva.

DNDi Director: ‘Reality Check’ Needed For Neglected Diseases

Research and development into neglected diseases - those predominately affecting poorer populations and for which there is little commercial incentive - is undergoing "remarkable advances and rude set-backs," says Bernard Pécoul, executive director of the Drugs for Neglected Diseases initiative (DNDi). Now, governments need to show stronger leadership in bringing about long-term solutions, he said.

WIPO Director General Election: How It Works

On 6 March, the United Nations World Intellectual Property Organization will hold its once-every-six-year election for a director general, a prized post in the multilateral system. Tomorrow (4 February), the candidates will face member states and take questions. Intellectual Property Watch explains the process.

WIPO Issues Tribute To Pete Seeger

The World Intellectual Property Organization has posted a tribute to legendary American folk singer, songwriter and activist Pete Seeger, who died on 27 January at the age of 94.

MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken

Following news reports that pharmaceutical producer AstraZeneca will end its spending on early stage research and development for tuberculosis, malaria and neglected tropical diseases, Médecins Sans Frontières issued a statement saying the move is further proof that substantive change to the global pharmaceutical R&D system is needed.